Arkolith/Insider Trading/PRTK/Form 4

Franson Timothy R

DirectorParatek Pharmaceuticals, Inc. (PRTK) · full profile →Form 4 · filed Feb 23, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2023Sell(S)7K$1.88$13K72K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000904454-23-000176) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML